Organization
University of Caen Hospital Centre
1 abstract
Abstract
Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail patients with RRMM: Results of the multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myélome (IFM).Org: University Hospital of Nantes, France, Centre Hospitalier Universitaire de Poitiers, CHU Grenoble Alpes, Lille University Hospital, APHP Hôpital Avicenne,